Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Mar-22 9:03 PM View:  | Kim Anthony H. Chief Financial Officer | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Grant | 150,512 | -- | -- | 100% 0 to 150.51K | |
| 28-Mar-22 9:06 PM View: | Hoang Peter L. President and CEO Director | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Payment of Exercise | 48,376 | $0.48 | $23,452.70 | (9%) 531.66K to 483.29K | |
| 28-Mar-22 9:04 PM View: | Vera Juan Chief Scientific Officer & COO Director | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Grant | 140,823 | -- | -- | 5% 2.56M to 2.71M | |
| 28-Mar-22 9:03 PM View: | Kim Anthony H. Chief Financial Officer | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Payment of Exercise | 36,076 | $0.48 | $17,489.60 | (24%) 150.51K to 114.44K | |
| 28-Mar-22 9:04 PM View: | Vera Juan Chief Scientific Officer & COO Director | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Payment of Exercise | 33,465 | $0.48 | $16,223.80 | (1%) 2.71M to 2.67M | |
| 28-Mar-22 9:06 PM View: | Hoang Peter L. President and CEO Director | Marker Therapeutics, Inc. (MRKR) | 24-Mar-22 | Grant | 199,094 | -- | -- | 60% 332.57K to 531.66K | |
| 10-Jun-21 6:55 PM View: | Elms Steve Director | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | < 1% 3.16M to 3.17M | |
| 10-Jun-21 6:56 PM View: | Laskow-Pooley David Director | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | 30% 42.56K to 55.22K | |
| 10-Jun-21 6:53 PM View: | Wilson John Robert Director | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | < 1% 7.8M to 7.81M | |
| 10-Jun-21 6:54 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | 52% 24.28K to 36.94K | |
| 10-Jun-21 6:57 PM View: | Wasserman Frederick Gerald Director | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | 24% 52.56K to 65.22K | |
| 20-May-21 4:32 PM View: | Wasserman Frederick Gerald Director | Marker Therapeutics, Inc. (MRKR) | 18-May-21 | Market Purchase | 10,000 | $2.41 | $24,098.00 | 23% 42.56K to 52.56K | (100%) |
| 08-Jun-23 9:35 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 25-Mar-21 | Gift | 14,285 | -- | -- | (46%) 31.0K to 16.71K | |
| 08-Jun-23 9:35 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 25-Mar-21 | Gift | 14,284 | -- | -- | 85% 16.71K to 31.0K | |
| 18-Mar-21 4:38 PM View: | Vera Juan Chief Development Officer | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 571,428 | $1.75 | $999,999.00 | 29% 1.99M to 2.56M | (100%) |
| 18-Mar-21 5:09 PM View: | Baskett Forest 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:15 PM View: | Makhzoumi Mohamad 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:17 PM View: | Sonsini Peter W. 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 4:35 PM View: | Elms Steve Director | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 1,142,860 | $1.75 | $2,000,000.00 | 57% 2.02M to 3.16M | (100%) |
| 18-Mar-21 5:11 PM View: | Behbahani Ali 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:12 PM View: | Chang Carmen 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:16 PM View: | Makower Joshua 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 4:39 PM View: | Wilson John Robert Director | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 1,714,280 | $1.75 | $3,000,000.00 | 28% 6.09M to 7.8M | (100%) |
| 08-Jun-23 9:35 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Purchase | 14,285 | $17.50 | $249,988.00 | 588% 2.43K to 16.71K | |
| 18-Mar-21 4:36 PM View: | Hoang Peter L. President and CEO Director | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 142,857 | $1.75 | $250,000.00 | 75% 189.71K to 332.57K | (100%) |
| 18-Mar-21 5:18 PM View: | Walker Paul Edward 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:08 PM View: | New Enterprise Associates 1... 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:14 PM View: | Florence Anthony A. Jr. 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 18-Mar-21 5:17 PM View: | Sandell Scott D 10% Owner | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 12-Feb-21 10:00 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | 234% 7.26K to 24.28K | |
| 12-Feb-21 10:00 PM View: | Wasserman Frederick Gerald Director | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | 67% 25.54K to 42.56K | |
| 12-Feb-21 10:00 PM View: | Elms Steve Director | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | < 1% 2.0M to 2.02M | |
| 12-Feb-21 10:00 PM View: | Laskow-Pooley David Director | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | 67% 25.54K to 42.56K | |
| 12-Feb-21 10:00 PM View: | Wilson John Robert Director | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | < 1% 6.07M to 6.09M | |
| 20-Feb-20 4:50 PM View: | Eastern Capital Ltd 10% Owner | Marker Therapeutics, Inc. (MRKR) | 18-Feb-20 | Exercise (in-the money or at-the-money) | 416,667 | $1.20 | $500,000.00 | 11% 3.63M to 4.05M | |
| 15-Aug-19 4:33 PM View: | Hoang Peter L. President and CEO Director | Marker Therapeutics, Inc. (MRKR) | 14-Aug-19 | Market Purchase | 10,000 | $4.62 | $46,200.00 | 6% 179.71K to 189.71K | |
| 13-May-19 4:01 PM View: | Wasserman Frederick Gerald Director | Marker Therapeutics, Inc. (MRKR) | 09-May-19 | Grant | 7,260 | -- | -- | 40% 18.28K to 25.54K | |
| 13-May-19 4:01 PM View: | Laskow-Pooley David Director | Marker Therapeutics, Inc. (MRKR) | 09-May-19 | Grant | 7,260 | -- | -- | 40% 18.28K to 25.54K | |
| 13-May-19 4:02 PM View: | Wilson John Robert Director | Marker Therapeutics, Inc. (MRKR) | 09-May-19 | Grant | 7,260 | -- | -- | < 1% 6.06M to 6.07M | |
| 13-May-19 4:02 PM View: | Eansor N David Director | Marker Therapeutics, Inc. (MRKR) | 09-May-19 | Grant | 7,260 | -- | -- | 100% 0 to 7.26K | |
| 17-Oct-18 8:50 AM View: | Reddish Mark Director | Marker Therapeutics, Inc. (MRKR) | 16-Oct-18 | Grant | 4,106 | -- | -- | 13% 32.0K to 36.11K | |
| 17-Oct-18 8:48 AM View: | Laskow-Pooley David Director | Marker Therapeutics, Inc. (MRKR) | 16-Oct-18 | Grant | 5,168 | -- | -- | 39% 13.12K to 18.28K | |
| 17-Oct-18 8:54 AM View: | Silverman Joshua Director | Marker Therapeutics, Inc. (MRKR) | 16-Oct-18 | Grant | 4,106 | -- | -- | 2% 166.45K to 170.55K | |
| 17-Oct-18 8:52 AM View: | Grisewood Sherry Director | Marker Therapeutics, Inc. (MRKR) | 16-Oct-18 | Grant | 4,106 | -- | -- | 27% 15.48K to 19.58K | |
| 17-Oct-18 8:45 AM View: | Wasserman Frederick Gerald Director | Marker Therapeutics, Inc. (MRKR) | 16-Oct-18 | Grant | 5,168 | -- | -- | 39% 13.12K to 18.28K | |
| 10-Oct-18 4:50 PM View: | Wilson Glynn Director | Marker Therapeutics, Inc. (MRKR) | 09-Oct-18 | Payment of Exercise | 7,561 | -- | -- | (4%) 189.34K to 181.78K | |
| 10-Oct-18 4:50 PM View: | Wilson Glynn Director | Marker Therapeutics, Inc. (MRKR) | 09-Oct-18 | Grant | 31,120 | -- | -- | 20% 158.22K to 189.34K | |
| 16-May-18 5:28 PM View: | Eastern Capital Ltd 10% Owner | Marker Therapeutics, Inc. (MRKR) | 14-May-18 | Private Purchase | 1,300,000 | $2.40 | $3,120,000.00 | 32% 4.0M to 5.3M | |
| 02-Mar-18 5:54 PM View: | Silverman Joshua Director | Marker Therapeutics, Inc. (MRKR) | 28-Feb-18 | Acquisition (other) | 153,333 | -- | -- | 100% 0 to 153.33K | |
| 25-Sep-17 3:11 PM View: | Hoang Peter L. CEO and President Director | Marker Therapeutics, Inc. (MRKR) | 22-Sep-17 | Payment of Exercise | 70,289 | $3.18 | $223,519.00 | (28%) 250.0K to 179.71K | (100%) |
